Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors

Title
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
Authors
Keywords
Bi-specific TCR, ImmTAC, Cancer immunotherapy, NY-ESO-1, LAGE-1, Time-domain
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 62, Issue 4, Pages 773-785
Publisher
Springer Nature
Online
2012-12-21
DOI
10.1007/s00262-012-1384-4

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started